ECM
CRL icon

ExodusPoint Capital Management’s Charles River Laboratories CRL Stock Holding History

ExodusPoint Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,469
Closed -$2.5M – 1647
2026
Q1 		$2.5M Buy
+14,469
New +$2.68M 0.02% 698
2025
Q4 		– Sell
-49,700
Closed -$7.78M – 1634
2025
Q3 		$7.78M Buy
+49,700
New +$7.89M 0.08% 267
2024
Q4 		– Sell
-1,979
Closed -$390K – 1606
2024
Q3 		$390K Buy
+1,979
New +$411K ﹤0.01% 1282
2024
Q1 		– Sell
-38,838
Closed -$9.18M – 1569
2023
Q4 		$9.18M Sell
38,838
-26,296
-40% -$5.17M 0.06% 218
2023
Q3 		$12.8M Buy
65,134
+50,798
+354% +$10.4M 0.12% 178
2023
Q2 		$3.01M Sell
14,336
-45,754
-76% -$9.1M 0.02% 648
2023
Q1 		$12.1M Buy
60,090
+52,271
+669% +$11.8M 0.1% 220
2022
Q4 		$1.7M Buy
+7,819
New +$1.71M 0.02% 720
2022
Q1 		– Sell
-2,997
Closed -$1.13M – 2265
2021
Q4 		$1.13M Buy
+2,997
New +$1.16M 0.01% 1008
2021
Q2 		– Sell
-96,183
Closed -$27.9M – 2420
2021
Q1 		$27.9M Buy
96,183
+84,720
+739% +$23.5M 0.41% 27
2020
Q4 		$2.86M Sell
11,463
-49,620
-81% -$11.8M 0.03% 413
2020
Q3 		$13.8M Buy
+61,083
New +$12.7M 0.28% 50
2019
Q4 		– Sell
-1,700
Closed -$225K – 1584
2019
Q3 		$225K Buy
+1,700
New +$228K 0.01% 1056

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

ExodusPoint Capital Management's CRL Position: Q2 2026 in Review

ExodusPoint Capital Management sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 14,469 shares — an estimated $2.5M sold.

ExodusPoint Capital Management first reported a position in CRL in Q3 2019 and held it in 13 quarters. The position peaked at $27.9M in Q1 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • ExodusPoint Capital Management reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 14,469 Charles River Laboratories shares in Q2 2026, an estimated $2.5M.
  • ExodusPoint Capital Management first reported a position in Charles River Laboratories in Q3 2019 and held it in 13 quarters.
  • ExodusPoint Capital Management's Charles River Laboratories position peaked at $27.9M in Q1 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.